Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.8900
+0.0399 (4.69%)
At close: Nov 18, 2025, 4:00 PM EST
0.8900
0.00 (0.00%)
After-hours: Nov 18, 2025, 4:10 PM EST

Sutro Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Cash & Equivalents
65.93190.369.2747.2530.41206.15
Upgrade
Short-Term Investments
101.67126.59306.35287.11167.52161.99
Upgrade
Cash & Short-Term Investments
167.59316.9375.62334.36197.94368.14
Upgrade
Cash Growth
-56.83%-15.63%12.34%68.92%-46.23%212.34%
Upgrade
Receivables
3.928.6236.087.1212.455.56
Upgrade
Prepaid Expenses
10.617.89.8511.678.124.49
Upgrade
Total Current Assets
182.11343.31421.54353.15218.52378.18
Upgrade
Property, Plant & Equipment
26.6935.8744.7651.0651.5912.94
Upgrade
Long-Term Investments
----68.78-
Upgrade
Other Long-Term Assets
0.868.034.442.732.532.99
Upgrade
Total Assets
209.66387.21470.74406.94341.41394.11
Upgrade
Accounts Payable
7.0310.489.444.86.015.54
Upgrade
Accrued Expenses
32.1440.1334.124.8317.078.82
Upgrade
Current Portion of Long-Term Debt
--4.0612.59.38-
Upgrade
Current Portion of Leases
7.967.486.424.591.04-
Upgrade
Current Income Taxes Payable
-0.0215.17---
Upgrade
Current Unearned Revenue
8.9869.7820.6716.765.514.6
Upgrade
Other Current Liabilities
15.794.013.93.082.750.63
Upgrade
Total Current Liabilities
71.9131.8993.7566.5541.7429.6
Upgrade
Long-Term Debt
---3.7715.7424.55
Upgrade
Long-Term Leases
9.715.6723.1529.5731.22-
Upgrade
Long-Term Unearned Revenue
213.64193.35202.4989.89-6.1
Upgrade
Other Long-Term Liabilities
1.691.691.690.120.151.82
Upgrade
Total Liabilities
296.93342.61321.09189.988.8462.06
Upgrade
Common Stock
0.090.080.060.060.050.05
Upgrade
Additional Paid-In Capital
843.81831.35708.98670.22586.24559.75
Upgrade
Retained Earnings
-931.19-786.87-559.41-452.62-333.41-227.87
Upgrade
Comprehensive Income & Other
0.030.040.02-0.62-0.310.13
Upgrade
Total Common Equity
-87.2744.6149.65217.05252.56332.05
Upgrade
Shareholders' Equity
-87.2744.6149.65217.05252.56332.05
Upgrade
Total Liabilities & Equity
209.66387.21470.74406.94341.41394.11
Upgrade
Total Debt
17.6623.1533.6450.4357.3724.55
Upgrade
Net Cash (Debt)
149.93293.74341.98283.93209.34343.59
Upgrade
Net Cash Growth
-58.74%-14.11%20.45%35.63%-39.07%177.99%
Upgrade
Net Cash Per Share
1.793.825.685.604.5410.55
Upgrade
Filing Date Shares Outstanding
85.1483.7862.4460.1646.3845.89
Upgrade
Total Common Shares Outstanding
85.182.5361.0157.546.3345.75
Upgrade
Working Capital
110.22211.42327.8286.61176.78348.59
Upgrade
Book Value Per Share
-1.030.542.453.775.457.26
Upgrade
Tangible Book Value
-87.2744.6149.65217.05252.56332.05
Upgrade
Tangible Book Value Per Share
-1.030.542.453.775.457.26
Upgrade
Machinery
-42.124037.6331.8232.79
Upgrade
Construction In Progress
-0.50.51.690.511.08
Upgrade
Leasehold Improvements
-24.2123.6123.2223.6515.9
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q